glp-1 bowel obstruction legal team in michigan Malpractice Lawyer Untangling GLP-1 Risks: Are Side
Description
FDA warning : Patients with a personal/family history of medullary thyroid carcinoma or MEN2 syndrome should avoid these medications

Wadden TA, Bailey TS, Billings LK et al (2021) Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial

Case Report Four weeks after being prescribed semaglutide, a 70-year-old woman presented to the emergency department (ED) with shortness of breath

GLP-1 patients fall into that category

Or you might conclude that semaglutide is not working for you and switch medications entirely
Some studies suggest a potentially higher risk with semaglutide, but more research is needed to confirm these findings
